4D Molecular Therapeutics News

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 11, 2024 05:20

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 2, 2024 04:45

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 25, 2024 05:41

4D Molecular Therapeutics | 424B5: Prospectus

Jun 8, 2024 05:09

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 2, 2024 04:36

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 9, 2024 05:52

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 9, 2024 05:28

4D Molecular Therapeutics | 424B5: Prospectus

Feb 9, 2024 05:26

4D Molecular Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 8, 2024 02:51

4D Molecular Therapeutics | 424B5: Prospectus

Feb 6, 2024 06:29

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 23, 2024 13:00

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 5, 2024 13:00

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 4, 2024 13:00

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 19, 2023 06:16

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 16, 2023 06:24

4D Molecular Therapeutics | EFFECT: Others

Aug 16, 2023 12:15

4D Molecular Therapeutics | 424B5: Prospectus

May 9, 2023 05:03

4D Molecular Therapeutics | 424B5: Prospectus

May 5, 2023 04:31

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 22, 2023 05:20

4D Molecular Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 22, 2023 04:31